Sun Pharma Advanced Research Company Limited has posted net loss of Rs. 81.99 crores for the period ended March 31, 2023 as against net profit of Rs. 10.15 crores for the period ended December 31, 2022. The company posted net loss of Rs. 71.05 crores for the period ended March 31, 2022.

The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023 as compared to Rs. 131.12 crores during the period ended December 31, 2022. The company reported total income of Rs.25.46 crores during the period ended March 31, 2022. 

For the Financial Year ended March 31, 2023, Sun Pharma Advanced Research Company has reported total income of Rs.249.66 crores as compared to Rs.144.09 crores during the Financial Year ended March 31, 2022.

The company has posted net loss of Rs. 222.58 crores for the Financial Year ended March 31, 2023 as against net loss of Rs. 203.40 crores for the Financial Year ended March 31, 2022.